Masaru Yamamoto

发表

Mononuclear Phagocytes Peptide Degradation by Human β Amyloid-Cytokine-Mediated Inhibition of Fibrillar

Shannon M Walsh, T. Kiyota, J. Kipnis, 2008 .

Cytokine-Mediated Inhibition of Fibrillar Amyloid-β Peptide Degradation by Human Mononuclear Phagocytes1

Shannon M Walsh, T. Kiyota, J. Kipnis, 2008, The Journal of Immunology.

Loss of Cadherin-11 Adhesion Receptor Enhances Plastic Changes in Hippocampal Synapses and Modifies Behavioral Responses

T. Manabe, T. Miyakawa, M. Takeichi, 2000, Molecular and Cellular Neuroscience.

Kinetic Analysis of Aggregated Amyloid-β Peptide Clearance in Adult Bone-marrow-derived Macrophages from APP and CCL2 Transgenic Mice

Shannon M Walsh, T. Kiyota, T. Ikezu, 2007, Journal of Neuroimmune Pharmacology.

Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells.

T. Kiyota, K. Kaibuchi, T. Ikezu, 2008, The American journal of pathology.

Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition.

James L. Buescher, H. Gendelman, R. Ransohoff, 2005, The American journal of pathology.

Interferon-and Tumor Necrosis Factor-Regulate Amyloid-Plaque Deposition and-Secretase Expression in Swedish Mutant APP Transgenic Mice

James L. Buescher, Shannon M Walsh, H. Gendelman, 2007 .

Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.

James L. Buescher, Shannon M Walsh, H. Gendelman, 2007, The American journal of pathology.

Overexpression of monocyte chemotactic protein-1/ CCL2 in β-amyloid precursor protein transgenic mice show accelerated diffuse β-amyloid deposition

James L. Buescher, H. Gendelman, R. Ransohoff, 2005 .

CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction

H. Xiong, H. Gendelman, R. Ransohoff, 2009, PloS one.

AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice.

H. Gendelman, R. Ransohoff, W. Klein, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice.

H. Gendelman, R. Ransohoff, W. Klein, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

CCR1 Chemokine Receptor

T. Ikezu, Masaru Yamamoto, 2008 .

CCR2 Chemokine Receptor

T. Ikezu, Masaru Yamamoto, 2008 .

AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice.

H. Gendelman, R. Ransohoff, W. Klein, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Interferon-(cid:2) and Tumor Necrosis Factor-(cid:3) Regulate Amyloid-(cid:4) Plaque Deposition and (cid:4) -Secretase Expression in Swedish Mutant APP Transgenic Mice

James L. Buescher, Shannon M Walsh, H. Gendelman, 2022 .